Top 10 canbas.co.jp Wettbewerber

nuvalent.com

Nuvalent is advancing a robust pipeline of novel drug candidates emphasizing kinase selectivity, with parallel lead programs for ROS1 and ALK NSCLC.

biohaven.com

Our portfolio includes treatments for a range of diseases with unmet medical needs.

amgenpro.jp

レパーサ皮下注140mgペン、皮下注420mgオートミニドーザーの製品基本・安全性情報（電子化された添付文書、インタビューフォーム、くすりのしおり、製品コード・バーコード、剤形写真など）をご覧いただけます。

frederick.cancer.gov

Given an input sequence or list of sequences as well as a CRISPR system with a defined spacer length and PAM sequence, sgRNA Scorer will identify putative sites and assign a predicted activity based on our new support vector machine model. In addition, an option exists to select sites with minimal off-target activity based on the CasFinder algorithm as well, enabling target sites to be selected with high predicted specificity and activity.

altoneuroscience.com

Interested in learning more about our differentiated approach to psychiatry? Get in touch with our team.

monterosatx.com

Pioneering Therapies for Cancer and Beyond – Our drug discovery platform is tailored to promote specific protein ubiquitination and subsequent proteasomal degradation of disease-causing, undruggable proteins, in essence leading to pharmacological protein knockout with high efficiency and accuracy.

bccrc.ca

transforming the lives of patients in british columbia through world-class cancer research.

parabilismed.com

The Helicon ERG degrader is intended to provide a novel therapeutic option for patients with castrate-resistant prostate cancer.